Drug class in one race

Serotonin 5-HT2A receptor (antagonist / inverse agonist) drugs for Atherosclerotic Cardiovascular Disease

2 tracked Serotonin 5-HT2A receptor (antagonist / inverse agonist) drugs in the Atherosclerotic Cardiovascular Disease race. The class explanation lives on the Serotonin 5-HT2A receptor (antagonist / inverse agonist) page; the full indication pipeline across every mechanism is on the Atherosclerotic Cardiovascular Disease page.

Head-to-head evidence: Anplag tab vs Sarpogrelate

← all Serotonin 5-HT2A receptor (antagonist / inverse agonist) drugs